Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals-Reference-Cited by-同舟云学术

Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals

Published:2022-04-22 Issue:4 Volume:5 Page:e2210871
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

De Marco Lorenzo¹,D’Orso Silvia¹,Pirronello Marta¹,Verdiani Alice¹,Termine Andrea²,Fabrizio Carlo²,Capone Alessia³,Sabatini Andrea³,Guerrera Gisella¹,Placido Roberta¹,Sambucci Manolo¹,Angelini Daniela F.¹,Giannessi Flavia¹,Picozza Mario¹,Caltagirone Carlo⁴,Salvia Antonino⁵,Volpe Elisabetta³,Balice Maria Pia⁶,Rossini Angelo⁵,Rötzschke Olaf⁷,Giardina Emiliano⁸⁹,Battistini Luca¹,Borsellino Giovanna¹

Affiliation:

1. Neuroimmunology Unit, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

2. Data Science Unit, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

3. Molecular Neuroimmunology Unit, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

4. Department of Clinical and Behavioral Neurology, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

5. Medical Services, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

6. Clinical Microbiology Laboratory, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

7. Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore

8. Genomic Medicine Laboratory Unione Italiana Lotta alla Distrofia Muscolare, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

9. Medical Genetics Laboratory, Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2791449/de_marco_2022_oi_220328_1650475575.1048.pdf

Reference16 articles.

1. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.;Liu;Nature,2022

2. A very high level of crossreactivity is an essential feature of the T-cell receptor.;Mason;Immunol Today,1998

3. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals.;Tarke;Cell Rep Med,2021

4. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals.;Grifoni;Cell,2020